Breaking Research News from Breastcancer.org
Comments
-
Small Study Suggests App Helps Women Exercise More, Lose Weight After Breast Cancer Diagnosis
December 4, 2018
A smartphone app giving women real-time contact with their healthcare team can help breast cancer survivors lose weight. Read more...0 -
Kadcyla Seems Better Than Herceptin for Early-Stage, HER2-Positive Residual Breast Cancer
December 13, 2018
The KATHERINE trial suggests that Kadcyla (chemical name: T-DM1 or ado-trastuzumab emtansine) improves disease-free survival compared to Herceptin (chemical name: trastuzumab) in people diagnosed with early-stage, HER2-positive disease who have cancer cells found in tissue removed during surgery after chemotherapy that includes a taxane and Herceptin or Herceptin and Perjeta (chemical name: pertuzumab). Read more...0 -
New Analysis Shows Immunotherapy Tecentriq Only Effective in PD-L1-Positive Breast Cancer
December 14, 2018
A new analysis of the IMpassion130 trial found that the immunotherapy Tecentriq (chemical name: atezolizumab) in combination with the chemotherapy Abraxane (chemical name: albumin-bound paclitaxel or nab-paclitaxel) only helps treat cancers that are PD-L1-positive. Read more...0 -
Delaying Chemotherapy More Than 30 Days Linked to Worse Outcomes for Triple-Negative Breast Cancer
December 18, 2018
People diagnosed with early-stage, triple-negative breast cancer who waited more than 30 days after surgery to start chemotherapy had a higher risk of recurrence and worse survival than people who started treatment within 30 days after surgery. Read more...0 -
Low-Dose Tamoxifen May Be an Option to Reduce Risk of Recurrence, Invasive Disease After Non-Invasive Breast Cancer
December 18, 2018
A low dose of tamoxifen after surgery reduced the risk of recurrence, as well as the risk of new invasive disease, in women diagnosed with hormone-receptor-positive breast intraepithelial neoplasia. Read more...0 -
Lymph Node Radiation, Surgery Offer Similar Outcomes After Positive Sentinel Node in Early-Stage Breast Cancer
December 19, 2018
Ten years of follow-up found lymph node radiation and lymph node surgery offer similar recurrence and overall survival rates for women diagnosed with early-stage breast cancer with a positive sentinel node. Read more...0 -
Accelerated Partial-Breast Radiation Slightly Less Effective Than Whole-Breast Radiation for Preventing Breast Cancer Recurrence After Lumpectomy
December 19, 2018
Accelerated partial-breast radiation after lumpectomy was pretty close, but a little less effective at reducing the risk of breast cancer recurrence in the same breast as whole-breast radiation in women diagnosed with early-stage disease, according to long-term study results. Read more...0 -
Regular Exercise During Treatment After Breast Cancer Surgery Offers Benefits
December 21, 2018
Women who followed a supervised, structured exercise program during treatment after surgery for stage I or stage II breast cancer had better heart health compared to women who weren't part of the exercise program. Read more...0 -
Overactive Bladder Medicine Helps Ease Hot Flashes in Women Treated for Breast Cancer
December 21, 2018
Oxybutynin, a medicine commonly used to treat bladder incontinence, reduced the number and severity of hot flashes in women treated for breast cancer. Read more...0 -
Surgery Choice for Early-Stage Breast Cancer Seems to Affect Younger Women's Quality of Life
December 21, 2018
Younger women diagnosed with early-stage breast cancer who opted for mastectomy reported lower satisfaction with their breasts and worse sexual and psychosocial well-being than women who chose lumpectomy. Read more...0 -
BMI Not Best Measure of Body Fat When Estimating Breast Cancer Risk in Postmenopausal Women
January 2, 2019
A study suggests more detailed measures of body fat, such as a DEXA scan, are better than BMI when estimating breast cancer risk in postmenopausal women. Read more...0 -
FDA Approves Herceptin Biosimilar Herzuma for HER2-Positive Breast Cancer
January 3, 2019
On Dec. 14, 2018, the FDA approved Herzuma, a biosimilar for Herceptin, to treat people with HER2-positive breast cancer. Read more...0 -
TAILORx Data Show Black Women Have Worse Breast Cancer Outcomes Than White Women Despite Similar Treatment
January 3, 2019
Black women diagnosed with early-stage, hormone-receptor-positive, HER2-negative breast cancer had higher rates of recurrence (the cancer coming back) and worse survival compared to white women with the same diagnosis, even though all the women received similar treatment. Read more...0 -
Current Breast Cancer Genetic Testing Guidelines Leave Out Many People With Harmful Mutations
January 4, 2019
Another study suggests that many people diagnosed with breast cancer who have a genetic mutation linked to the disease don't have genetic testing because they don't meet current testing guidelines. Read more...0 -
Breast Cancer Protection From Childbirth Starts Later Than Thought
January 4, 2019
A study suggests that breast cancer risk reduction from pregnancy doesn't kick in until about 20 years after a woman's last pregnancy and that women who had a child at age 55 or younger had a slightly higher risk of breast cancer. Still, there are important things to know about the study. Read more...0 -
Multi-Gene Genetic Tests Don't Cause More Worry Than BRCA Testing Alone in Women Diagnosed With Breast Cancer
January 9, 2019
The results from panel genetic tests looking at a dozen or more genes can be more complex, but these results are not causing women diagnosed with breast cancer more worry than older tests looking at only one or two genes. Read more...0 -
Self-Administered Acupressure Helps Ease Anxiety, Pain, Depression After Breast Cancer Treatment
January 23, 2019
Acupressure done at home by women who were taught the technique helped reduce pain, anxiety, and depression after breast cancer treatment. Read more...0 -
Is Breast Cancer Linked to Higher Risk of Atrial Fibrillation?
January 31, 2019
Women diagnosed with breast cancer may have a higher risk of a type of heart problem called atrial fibrillation, according to a retrospective Danish study. Read more...0 -
Hope, Positivity, Family Support Help People With Advanced-Stage Cancer Live Well
February 1, 2019
People diagnosed with advanced-stage cancer who have hope and positivity, as well as family support, are able to live well during the end stages of the disease. Read more...0 -
FDA Approves Herceptin Biosimilar Ontruzant for HER2-Positive Breast Cancer
February 6, 2019
On Jan. 20, 2019, the U.S. Food and Drug Administration approved Ontruzant, a biosimilar for Herceptin. Read more...0 -
Mammograms Are Less Painful, Just as Effective When Women Control Compression
February 7, 2019
Mammograms are just as effective and cause less discomfort when women can control the amount of compression. Read more...0 -
Men Treated With Tamoxifen for Breast Cancer Have Higher Risk of Blood Clots
February 13, 2019
Men diagnosed with hormone-receptor-positive breast cancer treated with tamoxifen had more than twice the risk of developing a blood clot compared to men with a similar diagnosis who were not treated with tamoxifen. Read more...0 -
Mammograms, Breast Cancer Treatment Advances Have Saved Hundreds of Thousands of Lives in Last 30 Years
February 16, 2019
Since 1989, more than half a million breast cancer deaths have been prevented in the United States, thanks to mammography and improvements in treatment, according to American Cancer Society estimates. Read more...0 -
Online Therapy Helps Ease Effects of Hot Flashes and Night Sweats Caused by Breast Cancer Treatment
February 22, 2019
A specific type of online therapy, called internet-based cognitive behavioral therapy, can help reduce the toll of hot flashes, night sweats, and other menopausal symptoms caused by breast cancer treatments. Read more...0 -
Older Biological Age Compared to Chronological Age Linked to Increased Breast Cancer Risk
February 28, 2019
Research suggests that if a woman's biological age is older than her chronological age, her risk of breast cancer is increased; still, this absolute increase is small. Read more...0 -
The Glass Is Half Full: Women Have Many More Positive Than Negative Thoughts About Changes Due to Breast Cancer
March 2, 2019
Two years after being diagnosed with breast cancer, women had 4 times more positive than negative thoughts about the changes they experienced because of the disease. Read more...0 -
FDA Approves Injectable Herceptin for HER2-Positive Breast Cancer
March 6, 2019
On Feb. 28, 2019, the U.S. Food and Drug Administration approved Herceptin Hylecta, an injectable form of Herceptin. Read more...0 -
Tecentriq Approved as First Immunotherapy for Breast Cancer
March 8, 2019
On March 8, 2019, the FDA approved Tecentriq in combination with the chemotherapy medicine Abraxane as a first treatment for unresectable locally advanced or metastatic triple-negative, PD-L1-positive breast cancer. Read more...0 -
Women Who've Experienced Breast Cancer Suggest Changes to Ease Financial Burden of Disease
March 8, 2019
Women who had been treated for breast cancer suggested changes to insurance and supportive services to help ease financial problems related to a breast cancer diagnosis. Read more...0 -
FDA Issues Warning About Robotic Mastectomies, Other Cancer Surgeries
March 8, 2019
On Feb. 28, 2019, the FDA warned that the safety and effectiveness of robotic devices for mastectomy and other cancer surgeries have not been established. Read more...0
